Australia is Missing Out


Australia is missing out on a global “renaissance” of research into use of psychedelic drugs to treat mental health problems, two psychologists say.

International research projects investigating the use of psychedelics, such LSD and psilocybin, the psychoactive compound in so-called magic mushrooms, to treat addiction, anxiety and depression have gained momentum in recent years.

Dr Stephen Bright, who is vice-president of PRISM or Psychedelic Research in Science and Medicine, a not-for-profit lobby group, said there had been a “renaissance” in psychedelic science research after a decades-long global ban on the subject began to soften in the early 2000s.

However, he said Australia had been left behind and there were no trials afoot.

“We have some good treatments for some psychological conditions, but not for others,” he said.

Click here to read the full article

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search